MoleMe utilizes a chatbot to simulate the decision-making process of a professional dermatologist, in conjunction with the AI technology of ASKIN. It assists users in assessing the risk of mole changes and provides timely and appropriate recommendations within one minute. MoleMe has received recognition at the 16th National Startup Awards and published its AI research findings in the top dermatology medical journal, BJD, in 2020.
Features / strengths
1. The product features are integrated with the official LINE account, allowing users to use it for free by adding our official account on the LINE app.
2. Enables quick and preliminary screening and testing, saving significant time spent waiting in a clinic.
3. By combining daily screening AI tools with online consultations, this service has successfully expanded to the global overseas Chinese market, with the goal of establishing an online medical consultation service that complements physical healthcare.
Specification in detail